Mind Medicine (MNMD)

New Form 8-K - Mind Medicine Filed: 2025-09-04 AccNo: 0000950170-25-112973 Size: 233 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Mind Medicine (MNMD)

Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)

Elevai Labs (ELAB)

Northstrive Biosciences Announces Completion of Phase II of AI Development Program with YuvaBio Using MitoNova™ Artificial Intelligence (AI) Platform to Develop Therapies for Obesity and Cardiometabolic Diseases